Blrilanta® 60mg & 90mg (Ticagrelor) Tablets | Antiplatelet Cardiovascular Medicine

Blrilanta® (Ticagrelor) Tablets 60mg & 90mg

Blrilanta® Tablets contain Ticagrelor, a prescription antiplatelet medication used to help reduce the risk of serious cardiovascular events in appropriate patients. Available in 60mg and 90mg strengths, Blrilanta® is manufactured to meet high-quality pharmaceutical standards and is intended for use under the supervision of a qualified healthcare professional.

Whether prescribed after a heart attack, acute coronary syndrome (ACS), or specific cardiovascular procedures, Blrilanta® helps inhibit platelet activation and aggregation, supporting long-term cardiovascular management when used as directed.

Key Features

Available strengths: 60mg and 90mg

Active ingredient: Ticagrelor

Oral film-coated tablets

High-quality manufacturing standards

Prescription-only medicine

Suitable for global pharmaceutical distribution (where approved)

What is Ticagrelor?

Ticagrelor is a P2Y12 receptor antagonist (antiplatelet agent) that helps reduce platelet aggregation. By preventing blood platelets from sticking together, it lowers the risk of blood clot formation that may lead to serious cardiovascular complications such as heart attack or stroke in appropriately selected patients.

Indications

Blrilanta® (Ticagrelor) Tablets may be prescribed for patients with:

Acute Coronary Syndrome (ACS)

History of myocardial infarction (heart attack)

Certain patients following coronary stent placement

Other approved cardiovascular indications as determined by a healthcare professional

Treatment should always follow the prescribing physician's recommendation and local regulatory guidelines.

Available Strengths

Blrilanta® 90mg Tablets

Blrilanta® 90mg is commonly prescribed during the initial treatment period following an acute coronary syndrome event, as recommended by healthcare professionals.

Blrilanta® 60mg Tablets

Blrilanta® 60mg may be prescribed for eligible patients requiring continued long-term antiplatelet therapy after the initial treatment phase.

Dosage should only be determined by a qualified healthcare provider.

Benefits of Blrilanta®

Helps reduce platelet aggregation

Supports long-term cardiovascular care

Available in convenient tablet strengths

Manufactured under stringent quality standards

Suitable for prescription-based cardiovascular treatment plans

How Blrilanta® Works

Ticagrelor works by reversibly blocking the P2Y12 receptor on platelets. This prevents platelet activation and reduces the formation of harmful blood clots, helping lower the risk of future cardiovascular events in appropriate patients.

Dosage & Administration

Take exactly as prescribed by your healthcare provider.

Tablets may be taken with or without food.

Swallow the tablet whole or follow your physician's instructions.

Do not discontinue therapy without medical advice, as stopping treatment prematurely may increase cardiovascular risk.

Warnings & Precautions

Blrilanta® should be used only under medical supervision.

Do not use if you have:

Active bleeding

History of intracranial hemorrhage

Known hypersensitivity to Ticagrelor or any ingredient

Inform your healthcare provider about:

Planned surgery or dental procedures

Liver disease

Current medications, including anticoagulants and aspirin

Pregnancy or breastfeeding

Ticagrelor increases the risk of bleeding and should only be used as directed by a healthcare professional.

Possible Side Effects

Some patients may experience:

Bleeding or bruising

Nosebleeds

Shortness of breath (dyspnea)

Dizziness

Nausea

Seek immediate medical attention if you experience severe or uncontrolled bleeding or signs of an allergic reaction.

Storage

Store below the temperature recommended on the product label.

Protect from moisture and direct sunlight.

Keep out of reach of children.

Frequently Asked Questions

What is Blrilanta® used for?

Blrilanta® is a prescription Ticagrelor tablet used to reduce the risk of serious cardiovascular events in eligible patients as determined by a healthcare professional.

What strengths are available?

Blrilanta® is available in 60mg and 90mg film-coated tablets.

Is Blrilanta® an anticoagulant?

No. Blrilanta® is an antiplatelet medication, not an anticoagulant.

Can I stop taking Blrilanta® on my own?

No. Never stop taking Ticagrelor without consulting your healthcare provider, as doing so may increase the risk of cardiovascular events.

Why Choose Blrilanta®?

Blrilanta® combines quality manufacturing with the trusted active ingredient Ticagrelor to support healthcare professionals in the management of cardiovascular disease. Available in both 60mg and 90mg strengths, it offers flexible treatment options based on physician guidance and approved indications.

Contact Us

For product inquiries, export opportunities, regulatory documentation, or partnership information, please contact our pharmaceutical team.